Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs United States Oil ETF — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while United States Oil ETF trades at $120.05. Which is the better fit depends on your goals.
| BIO | USO | |
|---|---|---|
Market Cap | $8.02B | — |
Sector | Health | — |
52-Week High | $339.75 | $152.96 |
52-Week Low | $241.71 | $66.17 |
Enterprise Value | $7.84B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USO (United States Oil Fund) is trading at $117.79, up 8.36% with strong bullish momentum driven by escalating Middle East tensions. The technical picture shows the stock breaking above key resistance levels with overall bullish signals from moving averages and oscillators. Recent geopolitical developments, including U.S.-Iran hostilities and Strait of Hormuz disruptions, have propelled oil prices to one-month highs, directly benefiting this oil-focused ETF.
The outlook remains positive as supply constraints and geopolitical risks support higher oil prices, though overbought conditions on short-term RSI suggest potential near-term consolidation. Key risks include geopolitical de-escalation and global demand concerns. Analyst sentiment is constructive given the fund's 600%+ performance in 2026, but investors should monitor oil price volatility closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
